Business Of Biotech

Podcast autorstwa Matt Pillar - Poniedziałki

Poniedziałki

Kategorie:

221 Odcinki

  1. Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management

    Opublikowany: 13.06.2022
  2. The Biotech Beatdown With Allan Shaw

    Opublikowany: 6.06.2022
  3. Inflammation & Antibodies with Ampio Pharmaceuticals' Mike Martino, CEO

    Opublikowany: 30.05.2022
  4. What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.

    Opublikowany: 23.05.2022
  5. Running Interference: RNAi with Silence Therapeutics' Craig Tooman

    Opublikowany: 16.05.2022
  6. Live Biologics & The Microbiome With 4D pharma's Duncan Peyton

    Opublikowany: 9.05.2022
  7. Gene Tx For Renal Disease With Purespring CEO Richard Francis

    Opublikowany: 2.05.2022
  8. Fighting Blindness & Funding The Fight With Opus Genetics' CEO Ben Yerxa, Ph.D.

    Opublikowany: 25.04.2022
  9. Gynecological Cancer Therapies with Context Therapeutics' Martin Lehr

    Opublikowany: 18.04.2022
  10. Commensal Viral Vectors with Ring Therapeutics' Tuyen Ong, M.D.

    Opublikowany: 11.04.2022
  11. Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.

    Opublikowany: 4.04.2022
  12. Gene Therapies For Ocular Disease With Sparing Vision's Stéphane Boissel

    Opublikowany: 28.03.2022
  13. Biotech M&A Trends With Allan Shaw

    Opublikowany: 21.03.2022
  14. Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.

    Opublikowany: 14.03.2022
  15. CAR T-cells For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.

    Opublikowany: 7.03.2022
  16. AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D

    Opublikowany: 28.02.2022
  17. Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago

    Opublikowany: 21.02.2022
  18. Plant-Based Biologics With iBio's Randy Maddux

    Opublikowany: 14.02.2022
  19. NK Cell Therapy Accessibility With Shoreline Biosciences' Dr. Kleanthis Xanthopoulos

    Opublikowany: 7.02.2022
  20. A Hybrid mAb Manufacturing Model With John Glasspool

    Opublikowany: 31.01.2022

7 / 12

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.

Visit the podcast's native language site